Search

everythinglearnresearchcommunity

for

Search:↓

The meeting highlighted important advances in stem cell research and its potential for creating new medical treatments.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

The document concludes that computational methods using networks and various data can improve the process of finding new uses for existing drugs.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Nonionic liposomes are the best for delivering genes to skin cells.

MendelVar is a tool that helps identify important genes by combining GWAS data with Mendelian disease information.

3D culture helps maintain hair growth cells better than 2D culture and identifies key genes for potential hair loss treatments.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Finasteride use may be linked to rare testicular tumor, but more research needed.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

The issue covers reproductive health topics like cancer markers, incontinence treatments, and the impact of pre-term birth.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Finasteride affects frog testes by increasing testosterone, decreasing 5α-DHT, and impacting genes related to reproduction and other functions.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

AnnoPharma effectively identifies substances causing adverse drug reactions in medical abstracts.

Minoxidil may help reduce aging effects in brain cells.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Finasteride discontinuation increases sperm count in men.

Argan press cake extract might help grow hair and protect hair cells from damage and inflammation.

Human hair follicles may provide a noninvasive way to diagnose diseases and have potential in regenerative medicine.

Hair follicles have a more inactive cell cycle than other skin cells, which may help develop targeted therapies for skin diseases and cancer.

A new therapy for a skin blistering condition has not been developed yet.